Now, what big pharmaceutical is going to partner up and take Remplir into phase 3 trials in the US, we are so close yet so far, let’s hope towards the second half of the year or early next year
Such a waste, where Remplir could be doing good, with thousand of patients losing out because of the approval process / commercialisation process taking so long, let’s try and fast track this process and get Remplir to market
Now, what big pharmaceutical is going to partner up and take...
-
- There are more pages in this discussion • 399 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.5¢ |
Change
0.005(1.39%) |
Mkt cap ! $76.40M | |||
| Open | High | Low | Value | Volume |
| 36.5¢ | 37.0¢ | 36.0¢ | $2.864K | 7.871K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 136618 | 36.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.5¢ | 4400 | 1 |
View Market Depth
| Last trade - 15.53pm 26/06/2024 (20 minute delay) ? |
| OCC (ASX) Chart |